安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Venetoclax - Wikipedia
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML) [7][8][9]
- Venetoclax: Uses, Dosage, Side Effects, Warnings - Drugs. com
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or older or with other conditions that prevent intensive chemotherapy Venetoclax is used in combination with azacitidine, decitabine, or low-dose cytarabine
- VENCLEXTA® (venetoclax tablets): CLL SLL and AML Treatment
Discover VENCLEXTA® (venetoclax tablets): An oral therapy to help you fight certain blood cancers See full Prescribing and Safety information
- Venetoclax (oral route) - Side effects dosage
Venetoclax is used alone or together with other medicines (eg, acalabrutinib, obinutuzumab, rituximab) to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
- Venetoclax - NCI - National Cancer Institute
This page contains brief information about venetoclax and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
- Venetoclax Tablets: Uses Side Effects - Cleveland Clinic
What is this medication? VENETOCLAX (ven ET oh klax) treats leukemia and lymphoma It works by blocking a protein that causes cancer cells to grow and multiply This helps to slow or stop the spread of cancer cells
- VENCLEXTA® (venetoclax tablets) AML CLL SLL Treatment HCP Site
Concomitant use of VENCLEXTA with P-gp inhibitors or strong or moderate CYP3A inhibitors increases venetoclax exposure, which may increase the risk of TLS at initiation and during the ramp-up phase, and requires VENCLEXTA dose reduction
- Venclexta (venetoclax) dosing, indications, interactions, adverse . . .
Medscape - Indication dosing for Venclexta (venetoclax), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
|
|
|